SCHEMBL6544813

SCHEMBL6544813

CN(C(=O)OC(C)(C)C)c1cc(Oc2ccc(O)cc2C(C)(C)C)ccc1N

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
GAA P10253 1/20 0.39
ESRRA P11474 3/20 0.35
NR1I2 O75469 1/20 0.32
LMNA P02545 1/20 0.32
CYP2C9 P11712 1/20 0.32
MIF P14174 1/20 0.32
TYR P14679 1/20 0.32
ALOX15 P16050 1/20 0.32
HTT P42858 1/20 0.32
NFE2L2 Q16236 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HSP90AA1 P07900 1/20 0.31
PDK1 Q15118 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK3 Q15120 1/20 0.31
PDK4 Q16654 1/20 0.31
NR1H4 Q96RI1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6543097 0.88 PGR (0.33) HSP90AA1PDK1PDK2PDK3PDK4
SCHEMBL6544711 0.87 ESRRA (0.39) ALDH1A1GAAESRRALMNAALOX15
SCHEMBL6544374 0.85 PARP10 (0.38) ESRRA
SCHEMBL6544749 0.83 ALDH1A1 (0.38) ALDH1A1GAAESRRALMNAHTT
SCHEMBL6543598 0.83 ESRRA (0.50) ALDH1A1GAAESRRANR1H4
SCHEMBL6543994 0.83 ESRRA (0.39) ALDH1A1GAAESRRALMNAALOX15
SCHEMBL6543619 0.83 HDAC3 (0.39) CYP2C9
SCHEMBL6700998 0.82 HTR6 (0.36) ALDH1A1GAALMNACYP2C9MIF
SCHEMBL6544878 0.82 PARP10 (0.35) ESRRA
SCHEMBL6544812 0.81 ESRRA (0.33) ESRRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1022272-B1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS SANKYO CO (JP) 2004-05-26 EP disclosed
US-6432993-B1 BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 2002-08-13 US disclosed
EP-1022272-A1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS Sankyo Company Limited (JP) 2000-07-26 EP disclosed